The risk of secondary progressive multiple sclerosis is geographically determined but modifiable

S Sharmin; I Roos; S Simpson-Yap; C Malpas; M Martinez Sanchez; S Ozakbas; D Horakova; EK Havrdova; F Patti; R Alroughani; V Shaygannejad; G Izquierdo; S Eichau; C Boz; M Zakaria; M Onofrj; A Lugaresi; B Weinstock-Guttman; A Prat; M Girard; P Duquette; M Terzi; MP Amato; R Karabudak; F Grand'Maison; B Yamout; SJ Khoury; P Grammond; J Lechner-Scott; K Buzzard; O Skibina; A Van der Walt; H Butzkueven; R Turkoglu; A Altintas; Y Blanco; D Maimone; A Kermode; N Shalaby; V Van Pesch; E Butler; Y Sidhom; R Gouider; O Gerlach; A Soysal; M Barnett; J Kuhle; S Hughes; M Jose Sa; T Kalincik

Conference Proceedings

The risk of secondary progressive multiple sclerosis is geographically determined but modifiable

S Sharmin, I Roos, S Simpson-Yap, C Malpas, M Martinez Sanchez, S Ozakbas, D Horakova, EK Havrdova, F Patti, R Alroughani, V Shaygannejad, G Izquierdo, S Eichau, C Boz, M Zakaria, M Onofrj, A Lugaresi, B Weinstock-Guttman, A Prat, M Girard Show all

MULTIPLE SCLEROSIS JOURNAL | SAGE PUBLICATIONS LTD | Published : 2022

University of Melbourne Researchers

Sifat Sharmin Author

Izanne Roos Author

Steve Simpson-Yap Author

Charles Malpas Author

Related Projects (3)

PRECISION TREATMENT FOR MULTIPLE SCLEROSIS: MAXIMISING THE EFFECT OF IMMUNOMODULATORY THERAPY

Response to therapy varies greatly among patients with multiple sclerosis (MS). The current lack of individualised MS therapy may lead to su..

PRECISION THERAPY FOR NEUROLOGICAL DISEASES

Multiple sclerosis is the most common cause of neurological disability among young adults. The patients’ individual response to therapy is h..

Personalised therapy to prevent disability in aggressive multiple sclerosis

Keywords

Neurosciences & Neurology

Clinical Neurology

Neurosciences

Life Sciences & Biomedicine

Science & Technology